openPR Logo
Press release

Government Funding In Regenerative Medicine Is Propelling Growth Of Human Embryonic Stem Cells Market : Powering Innovation and Expansion in the Human Embryonic Stem Cells Market by 2025

08-07-2025 08:36 AM CET | Health & Medicine

Press release from: The Business Research Company

Human Embryonic Stem Cells

Human Embryonic Stem Cells

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Human Embryonic Stem Cells Market Through 2025?
The market for human embryonic stem cells has experienced swift expansion in the recent past. The market size is predicted to increase from $1.24 billion in 2024 to $1.37 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.5%. Factors contributing to the growth during this historic period include financial support and investments, regulatory approval, public consciousness, the introduction of regenerative medicine, and extended clinical applications.

What's the Projected Size of the Global Human Embryonic Stem Cells Market by 2029?
The growth of the human embryonic stem cells market is forecasted to accelerate briskly in the upcoming years, reaching a valuation of $2.02 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.1%. Factors driving this growth during the predicted period include a boost in the number of cell therapy manufacturing facilities, a heightened demand for restorative therapies, a surge in occurrences of heart diseases and cancers, progress in stem cell biology studies, and increased awareness about the therapeutic potential of stem cells. Key trends to look out for in the future include development in regenerative medicine, a heightened emphasis on individualized medicine, expanding uses in drug discovery and toxicology, technological advancements, and growth in biobanking.

View the full report here:
https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

Top Growth Drivers in the Human Embryonic Stem Cells Industry: What's Accelerating the Market?
The surge in the human embryonic stem cells market is likely influenced by increased government funding geared towards the expansion of regenerative medicine. As a healthcare sector concentrated on the repair, replacement, or regeneration of damaged tissues or organs to reinstate normal bodily functions, regenerative medicine is seeing escalating support from the government. This support stems from the higher incidence of chronic diseases, the progress in stem cell research, and the potential for new treatments that could enhance patient results. Human embryonic stem cells, integral to regenerative medicine, offer the potential to devise therapies that can repair or replace impaired tissues and organs in the body. For example, in May 2022, the Canadian Government allocated a three-year funding of $45 million, beginning from 2022-23, to the stem cell network as part of the Budget 2021 distribution, intensifying stem cell and regenerative medicine research. As a result, this substantial government commitment to the expansion of regenerative medicine is catalyzing the human embryonic stem cells market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16086&type=smp

What Trends Will Shape the Human Embryonic Stem Cells Market Through 2029 and Beyond?
Leading firms in the human embryonic stem cell industry have shifted their focus on diversifying therapeutic applications, like the use of pluripotent stem cells for treating Parkinson's disease, in their bid to establish a competitive advantage. The pluripotent stem cells in the treatment of Parkinson's disease work by creating dopaminergic neurons with the target of replacing the dopamine-producing neurons that have been lost and hence restore motor function. For instance, Bayer AG, a pharmaceutical and biotechnology firm based in Germany, in October 2023, initiated its first Cell Therapy Manufacturing Facility in California. It invested $250 million with the aim to manufacture cell and gene therapies on a global scale. The primary focus is on producing BlueRock Therapeutics' bemdaneprocel, which is derived from pluripotent stem cells (PSC) for treating Parkinson's disease. The facility is fully equipped with electrical manufacturing to tackle the industry's manufacturing capacity for regenerative medicines.

What Are the Main Segments in the Human Embryonic Stem Cells Market?
The human embryonic stem cells market covered in this report is segmented -

1) By Type: Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells
2) By Product: Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing
3) By Application: Research, Clinical Trials, Other Applications

Subsegments:
1) By Totipotent Stem Cells: Embryonic Totipotent Stem Cells, Induced Totipotent Stem Cells
2) By Pluripotent Stem Cells: Human Embryonic Stem Cells (hESCs), Induced Pluripotent Stem Cells (iPSCs), Embryonic Stem Cell Lines, Conditioned Pluripotent Stem Cells
3) By Unipotent Stem Cells: Somatic Stem Cells, Adult Stem Cells, Tissue-Specific Stem Cells

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16086&type=smp

Which Top Companies are Driving Growth in the Human Embryonic Stem Cells Market?
Major companies operating in the human embryonic stem cells market are Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KgaA, Astellas Pharma Inc., Lonza Group, PerkinElmer Inc., R&D Systems, LifeCell, Takara Bio Inc., ViaCyte Inc., PromoCell GmbH, CellGenix GmbH, PeproTech Inc., Lineage Cell Therapeutics Inc., BioTime, Asterias Biotherapeutics Inc., ESI BIO, STEMCELL Technologies Inc., TATAA Biocenter, Celgene Corporation

Which Regions Will Dominate the Human Embryonic Stem Cells Market Through 2029?
North America was the largest region in the human embryonic stem cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human embryonic stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16086

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Government Funding In Regenerative Medicine Is Propelling Growth Of Human Embryonic Stem Cells Market : Powering Innovation and Expansion in the Human Embryonic Stem Cells Market by 2025 here

News-ID: 4136452 • Views:

More Releases from The Business Research Company

Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by 2029
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025? Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billion by 2029
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Rheology Modifiers Industry? There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analysis Report
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025? In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growth at 7.1% CAGR Forecast
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Pharmaceutical Intermediates Industry? There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound

All 5 Releases


More Releases for Cell

Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY